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Summary
Background: Since the first description of infective endocarditis, the profile of the disease has
evolved continuously with stable incidence. However, epidemiological features are different in
developing countries compared with western countries.
Objective: To describe epidemiological, microbiological and outcome characteristics of infective
endocarditis in Tunisia.
Patients and methods: This was a descriptive multicenter retrospective study of inpatients
treated for infective endocarditis from 1991 to 2000. Charts of patients with possible or definite
infective endocarditis according to the Duke criteria were included in the study.
Results: Four hundred and forty episodes of infective endocarditis among 435 patients (242
males, 193 females; mean (SD) age = 32.4 (16.8) years, range 1—78 years) were reviewed. The
most common predisposing heart disease was rheumatic valvular disease (45.2%). Infective
endocarditis occurred on prosthetic valves in 17.3% of cases. Causative microorganisms were
identified in 50.2% of cases: streptococci (17.3%), enterococci (3.9%), staphylococci (17.9%), and* Corresponding author. Tel.: +216 73 21 11 83; fax: +216 73 21 11 83.
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other pathogens (11.1%). Blood cultures were negative in 53.6% and no microorganism was identified
in 49.8%. Early valve surgery was performed in 51.2% of patients. The in-hospital mortality was
20.6%.
Conclusion: Infective endocarditis is still frequently associated with rheumatic disease among young
adults in Tunisia, with a high frequency of negative blood cultures and high in-hospital mortality,
given that the population affected is relatively young.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Figure 1 Incidence of infective endocarditis by age and sex.
Table 1 Distribution of underlying heart disease in 440
cases of infective endocarditis
Underlying heart disease No. (%)
Native valve disease 364 (82.7)
Rheumatic valve disease 199 (45.2)
Not previously known 100 (22.7)
Congenital heart disease 39
Degenerative 24
Other 2
Prosthetic valve 76 (17.3)Introduction
Despite great medical progress, infective endocarditis (IE)
remains a serious infection with stable incidence. However,
profound changes have occurred in the epidemiological pro-
file of the disease, especially in developed countries where IE
more frequently affects older patients or IV addicts with a
decline in underlying rheumatic valvular disease and a larger
spectrum of causative microorganisms.1—6 These changes
have not been noted in developing countries.7,8
In Tunisia, epidemiological data are fragmentary and show
that IE is frequently associated with rheumatic valvular
disease resulting in high morbidity and mortality.9,10 The
aim of this multicenter study was to describe the epidemio-
logical characteristics of IE in Tunisia.
Patients and methods
This descriptive study was conducted retrospectively for a
10-year period, from 1991 to 2000, in almost all regions of
Tunisia. We analyzed the charts of all patients hospitalized, in
13 (from 18) cardiology or infectious diseases units, with a
diagnosis of IE. Inclusion criteria were definite or possible IE,
according to modified Duke criteria.11 The following data
were collected from those cases included: age, sex, under-
lying heart disease, predisposing conditions for bacteremia,
complications, echocardiographic and microbiological data,
surgical treatment, and outcome. For blood cultures, con-
ventional manual systems were used with at least three
aerobic and anaerobic bottles inoculated with blood, for
at least 14 days. Serological tests for brucella and coxiella
infections were performed in 17% and 12%, respectively, of IE
patients with negative blood cultures. However, antibodies
anti-bartonella, legionella and mycoplasma were not per-
formed.
Early surgery was undertaken, if indicated, up to two
months following the IE diagnosis. Since it was a retrospec-
tive study, only intra-hospital mortality was considered.
Statistical interpretation of data was performed using the
computerized software program SPSS version 13 (SPSS, Inc.,
Chicago, IL, USA).
Results
Among 510 notifications during the study period, 440 epi-
sodes of IE among 435 patients were retained (242 males, 193
females; mean (SD) age 32.4 (16.8) years) (Figure 1). Tunisia
has a population of 8 million; assuming that all cases are
reported, there would be 55 cases/1 000 000 inhabitants.
The incidence of IE was also stable during the 10-year period
of the study with at least 46 new cases per year.The mean (SD) duration of hospital stay was 37.6 (21.2)
days (range 0—99, median 39 days). Predisposing heart dis-
eases are listed in Table 1. Rheumatic valve disease was
noted in 45.2% of native valve IE, with a stable rate in the
last two years of 41.6%. No case of IE was associated with IV
drug use. IE locations were: mitral valve in 45.7%, aortic in
33.2%, mitral and aortic in 13.4%, and tricuspid in 4.5%. A
total of 218 cases (49.5%) had a confirmed or probable portal
of entry. Dental procedures/poor dental condition was the
most frequent cause of the bacteremia (n = 110), followed by
cutaneous route (n = 43), percutaneous iatrogenic proce-
dures and cardiac surgery (n = 23), and miscellaneous other
conditions (n = 42).
The median number of blood cultures drawn was three.
The causative microorganisms were identified by blood cul-
tures in 204 cases (46.4%) and by other methods in 17 (3.9%)
additional cases (six cultures of valve, six serological tests
and five in a metastatic location). Blood cultures remained
negative in 53.6% of cases and no microorganism was identi-
fied in 49.8%. Overall, streptococci, enterococci and staphy-
lococci were the most commonly isolated — 78% of the
identified causative microorganisms (Table 2). Congestive
heart failure and neurological complications were observed
in 45.2% and 20.2%, respectively (Table 3).
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Table 2 Distribution of causative microorganisms
Microorganism No. %
Streptococci 77 17.5
Oral streptococcus 47
Group D streptococci 10
S. pneumoniae 4
S. agalactiae 3
Non-identified streptococci 13
Enterococci 17 3.9
Staphylococci 79 17.9
S. aureus 52
Coagulase-negative 27
Enterobacteria 10 2.3
Brucella 5 1.1
Corynebacterium 5
Coxiella 3
Other microorganisms 26
Other Gram-negative bacilli 11
HACEK group 6
Candida albicans 4
Others 5
No microorganism identified 219 49.8
Table 3 Main complications observed in 440 cases of infec-
tive endocarditis
Complications No. %
Congestive heart failure 199 45.2
Neurological complications 89 20.2
Hemorrhagic and ischemic CVA 72 16.4
Cerebral abscess/meningitis 17 3.9
Peripheral vascular emboli, aneurism 23 5.2
Glomerulonephritis 12 2.7
Spleen abscess/infarction 9 2.0
CVA, cerebral vascular accident.During this period, 223 patients underwent valve surgery
after a median (interquartile range) 27 (14—50) days follow-
ing admission. Sixteen patients (4%) presented with a further
episode of IE on the prosthetic valve during the period of
study. The in-hospital mortality rate was 20.6% (90 patients).
Discussion
The real incidence of IE in our country could not be derived
from this study; however, it has demonstrated that this
disease remains frequent and serious with more than 46
cases per year and a mortality rate of 20.6%. Although not
all Tunisian centers participated, a major strength of our
study is the low influence of referral bias compared with most
previous studies, which have mainly been based on series in a
single tertiary center.
The low age of our patients (mean age = 32.4 years) is
comparable to that found in developing countries.8,12 In
contrast, in western studies an important shift has beenobserved over the last decades with the mean age of
affected patients being 55 to 60 years.1,3,13—15 This has
mainly been attributed to a dramatic decrease in the
incidence of acute rheumatic disease, increasing patient
longevity that has given rise to degenerative valvular
lesions, placement of prosthetic valves, and increased
exposure to nosocomial bacteremia.2,16 Although rheu-
matic disease was the most frequent underlying condition
in our study (45%), its incidence had decreased when com-
pared to the results of a study conducted in the seventies
(67%).9 On the other hand, we noted an increasing propor-
tion of IE in patients with no previously known heart disease
(27.5% versus 1%). This last pattern change should be
considered in the diagnosis of IE and the role of degenera-
tive valve lesions.1,4,16
As described in other series in developing coun-
tries,7,8,12,15 the most characteristic finding in our study
was the high frequency of IE negative blood cultures
(50%); in contrast, in series from industrialized countries,
blood cultures were found to be negative in 5—15% of IE
cases.1—4,14 The etiologic factors most incriminated in the
high frequency of IE negative blood cultures are previous
antibiotic therapy, lack of optimal conventional culture
techniques, and lack of systematic investigation for rare
and fastidious microorganisms.2,17—21 In a Tunisian study,
when sera of IE were tested systematically for fastidious
microorganisms associated with blood negative endocarditis,
a high prevalence of bartonella endocarditis (9.8% of all IE)
was observed.19
In this study, as in previous reports, when blood cultures
were positive, staphylococci and streptococci were the most
commonly isolated causative agents of IE (35.7% and 34.5%,
respectively). These twomicroorganisms have been reported
as etiological agents in 13—49% and 20—63% of cases of native
valve endocarditis, respectively.7,8,15 Only 1.1% of all IE were
caused by Brucella spp; this low rate in spite of the ende-
micity of brucellosis in our country is probably due to the
difficulty in isolating Brucella spp from blood cultures, in
addition to brucellosis serology not having been performed
systematically.
As in other reports,22,23 the major complications observed
in our population were congestive heart failure and cerebral
vascular accidents, noted in 45.2% and 16.4%, respectively.
These major complications have the greatest influence on
the prognosis of IE.24 The usual cause of congestive heart
failure in patients with IE is infection-induced valvular
damage, especially aortic valve infection.2 In this situation,
surgical therapy is usually the only choice, although timing of
surgery continues to be a matter for debate.23
The overall mortality in the present series was 20.6%
compared with 9—35% in others series.7,8,12,15 The mortality
of IE is largely dependent on the underlying conditions of the
population and timing of surgery in cases with congestive
heart failure.25
In conclusion, in our multicenter retrospective study, the
incidence of IE has continued to rise and the clinical pre-
sentation, site of valvular infection, and types of etiologic
microorganisms were typical of IE reported from the west.
Nevertheless, compared to patients with IE in developed
countries, notable differences in our study population
included a greater proportion of rheumatic heart disease
and a higher frequency of negative blood cultures. More
Epidemiology of infective endocarditis in Tunisia 433effort is needed in the areas of rheumatic heart prophylaxis
and negative blood culture IE explorations.
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